Adenoviral Vectors for Gene Therapy

Adenoviral Vectors for Gene Therapy

Edited by  , Edited by 

List price: US$300.00

Currently unavailable

Add to wishlist

AbeBooks may have this title (opens in new window).

Try AbeBooks


Adenoviral Vectors for Gene Therapy provides detailed and comprehensive coverage of these important therapeutic agents. The topics covered in this book range from the basic biology of adenoviruses, through the construction and purification of adenoviral vectors, cutting-edge vectorology and the use of adenoviral vectors in preclinical animal models, to regulatory issues which must be considered prior to the initiation of human clinical gene therapy trials. The broad scope of this unique volume provides the reader with a complete understanding of the development and use of adenoviral vectors.
show more

Product details

  • Hardback | 890 pages
  • 160 x 230 x 32mm | 1,079.54g
  • Academic Press Inc
  • San Diego, United States
  • English
  • New.
  • Illustrations (some col.)
  • 0121995046
  • 9780121995041

Review quote

"This is a well organized collection of reviews written by authorities in the field that covers key aspects in the use of adenovirus as a gene transfer vehicle. The complete coverage of so many different aspects of adenovirus vector biology will be invaluable to scientists beginning or well established in this rapidly changing field."
--DOODY'S (March 2003)
show more

About David T. Curiel

David T. Curiel, M.D., Ph.D. is the Director of the Cancer Biology Division of the Department of Radiation Oncology at Washington University School of Medicine. Dr. Curiel graduated medical school at Emory University in 1982, where he also completed his internship and residency in Internal Medicine. Dr. Curiel's scientific training includes tenureship at the National Institutes of Health in Bethesda, Maryland at the Pulmonary Branch of the Heart and Lung, and Blood Institute (NHLBI) from 1985-1989, and a fellowship in Biotechnology at the National Cancer Institute, Navy Medical Oncology Branch from 1989-1990. He received his Ph.D. from University of Groningen in The Netherlands in 2002. Dr. Curiel has been at Washington University School of Medicine since 2011. In addition to his role as Director of the Cancer Biology Division, he is Director of the Biologic Therapeutics Center.
show more

Table of contents

Adenovirus Structure

Biology of Adenovirus Cell Entry

Adenovirus Replication

Adenoviral Vector Construction I: Mammalian Systems

Adenoviral Vector Construction II: Bacterial Systems

Propagation of Adenoviral Vectors: Use of PER.C6 Cells

Purification of Adenovirus

Targeted Adenoviral Vectors I: Transductional Targeting

Targeted Adenoviral Vectors II: Transcriptional Targeting

Development of Attenuated Replication Competent Adenoviruses ARCAs) for the treatment of Prostate Cancer

Replication-Selective Oncolytic Adenovirus EI-Region Mutants: Virotherapy for Cancer

Innate Immune Responses to in Vivo Adenovirus Infection

Humoral Immune Response

Novel Methods to Eliminate the Immune Response to Adenovirus Gene Therapy

High-Capacity "Gutless" Adenoviral Vectors: Technical Aspects and Applications

Xenogenic Adenoviral Vectors

Hybrid Adenoviral Vectors

Utility of Adenoviral Vectors in Animal Models of Human Disease I: Cancer

Utiltity of Adenoviral Vectors in Animal Models of Human Disease II: Genetic Disease

Utility of Adenoviral Vectors in Animal Models of Human Disease III: Acquired Diseases

Testing of Adenoviral Vector Gene Transfer Products: FDA Expectations

Imaging Adenovirus-Medicated Gene Transfer
show more